Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

CRC 1 Bronchiolitis Obliterans Syndrome 1

Interventions

Leucovorin 2 Irinotecan 2 Fluorouracil 2 Cetuximab 2 spartalizumab 1 pembrolizumab 1 camrelizumab 1 Radiosurgery 1 Oxaliplatin 1 Oncolytic Virotherapy 1 KD025 1 IFL protocol 1 HLX07 1 Folfox protocol 1 Drug Therapy 1 CCT239065 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

CRC × KD025 × Clear all

NCT05382377 2022-05-19

NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors

The Affiliated Hospital of the Chinese Academy of Military Medical Sciences

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

CRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡